M

    Milestone Scientific (MLSS)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

    $0.48
    -0.02 (-4.34%)

    Market Cap: $42.31M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(22/39)
    Avg Surprise
    -42.95%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.01 - $-0.01
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.01+0.0%
    60d ago$-0.01+0.0%
    30d ago$-0.01+0.0%
    7d ago$-0.01+0.0%
    Current$-0.01
    Revenue Consensus
    $2M
    Range$2M - $3M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.01
    Range$-0.01 - $-0.01
    2 analysts
    Revenue Consensus
    $3M
    Range$2M - $3M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.01---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Aug 13
    		$-0.01$-0.01+0.00%Beat+50.0%
    Mar 26
    Reported May 13
    		$-0.01$-0.01+0.00%Beat+50.0%
    Dec 25
    Reported Mar 31
    		$-0.01$-0.01+0.00%Beat+66.7%
    Sep 25
    Reported Nov 13
    		$-0.01$-0.01+0.00%Beat+50.0%
    Jun 25
    Reported Aug 14
    		$-0.02$-0.01-100.00%Miss+0.0%
    Mar 25
    Reported Apr 15
    		$-0.02$-0.01-100.00%Miss+0.0%
    Dec 24
    Reported Mar 28
    		$-0.03$-0.01-200.00%Miss+0.0%
    Sep 24
    Reported Nov 14
    		$-0.02$-0.01-100.00%Miss+0.0%
    Jun 24
    Reported Aug 14
    		$-0.02$-0.01-100.00%Miss+33.3%
    Mar 24
    Reported May 15
    		$-0.02$-0.02+0.00%Beat+0.0%
    Dec 23
    Reported Mar 29
    		$-0.03$-0.02-50.00%Miss+0.0%
    Sep 23
    Reported Nov 14
    		$-0.02$-0.02+0.00%Beat+33.3%
    Jun 23
    Reported Aug 15
    		$-0.03$-0.02-50.00%Miss+25.0%
    Mar 23
    Reported May 11
    		$-0.02$-0.03+33.33%Beat+33.3%
    Dec 22
    Reported Mar 31
    		$-0.03$-0.03+0.00%Beat-50.0%
    Sep 22
    Reported Nov 15
    		$-0.03$-0.03+0.00%Beat+0.0%
    Jun 22
    Reported Aug 16
    		$-0.04$-0.03-33.33%Miss+0.0%
    Mar 22
    Reported Apr 1
    		$-0.03$-0.03+0.00%Beat-200.0%
    Dec 21
    Reported Mar 31
    		$-0.02$-0.03+33.33%Beat-100.0%
    Sep 21
    Reported Nov 15
    		$-0.03$-0.03+0.00%Beat-50.0%
    Jun 21
    Reported Aug 16
    		$-0.04$-0.02-100.00%Miss+33.3%
    Mar 21
    Reported Apr 1
    		$-0.01$-0.02+50.00%Beat+66.7%
    Dec 20
    Reported Mar 31
    		$-0.01$-0.02+50.00%Beat+80.0%
    Sep 20
    Reported Nov 17
    		$-0.02$-0.04+50.00%Beat+66.7%
    Jun 20
    Reported Aug 14
    		$-0.06$-0.04-50.00%Miss-200.0%
    Mar 20
    Reported May 15
    		$-0.03$-0.02-50.00%Miss-50.0%
    Dec 19
    Reported Mar 30
    		$-0.05$-0.02-150.00%Miss-600.0%
    Sep 19
    Reported Nov 14
    		$-0.06$-0.01-500.00%Miss+50.0%
    Jun 19
    Reported Aug 14
    		$-0.02$-0.02+0.00%Beat+50.0%
    Mar 19
    Reported Apr 1
    		$-0.02$-0.04+50.00%Beat+66.7%
    Dec 18
    Reported Dec 31
    		$0.01N/A+125.00%Beat+125.0%
    Sep 18
    Reported Nov 15
    		$-0.12$-0.04-200.00%Miss-140.0%
    Jun 18
    Reported Aug 14
    		$-0.04$-0.05+20.00%Beat-100.0%
    Mar 18
    Reported Apr 3
    		$-0.06$-0.02-200.00%Miss+0.0%
    Sep 17
    Reported Nov 15
    		$-0.04$-0.04+0.00%Beat+20.0%
    Jun 17
    Reported Aug 14
    		$-0.05$-0.05+0.00%Beat-
    Mar 17
    Reported Apr 3
    		$-0.02N/A+66.67%Beat-
    Dec 16
    Reported Mar 31
    		$-0.06$-0.05-20.00%Miss-
    Sep 16
    Reported Nov 9
    		$-0.05$-0.02-150.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-12.01EV/EBITDA-6.86x
    Price/FCF-67.99xFCF Yield-1.47%
    Profitability
    Profit Margin-44.00%Operating Margin-37.40%
    ROE-121.70%ROIC-82.35%
    Financial Health
    Debt/Equity0.13xInterest CoverageN/A
    Current Ratio1.85xQuick Ratio0.85x
    Trading Statistics
    Beta1.05Avg Volume188.70K
    52-Week High$0.6552-Week Low$0.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.49
    SMA 20$0.49
    SMA 50$0.42
    SMA 200$0.34
    EMA 10$0.49
    EMA 20$0.48
    EMA 50$0.44
    EMA 200$0.41

    MACD

    Line: 0.02Signal: 0.02Hist: -0.00

    ADX

    ADX: 26.3+DI: 26.2-DI: 15.2

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down16.0
    PSAR$0.44

    Bollinger Bands

    Upper Band$0.54
    Lower Band$0.44
    %B Position2069%(Upper)
    Band Width0.41

    RSI (14-Day)

    Neutral
    52.2

    Momentum Oscillators

    Stoch %K39.9
    Stoch %D48.0
    Williams %R-71.2
    ROC (10d)-1.6%
    Momentum-0.01
    CCI (20d)-9.2
    MFI (14d)61.8

    Volatility Measures

    ATR (14d)$0.04(7.9%)
    StdDev (20d)0.03
    Hist Vol79.3%(High)

    Volume Flow

    VWAP$0.48
    OBV-40.3M
    AD Line-67.5M
    CMF (20d)0.392

    Volume Metrics

    Avg Vol (20d)176.4K
    Vol Ratio0.2x(Low)
    VWMA (20d)$0.51

    Pivot Points

    R3$0.53
    R2$0.52
    R1$0.51
    Pivot Point$0.50
    S1$0.49
    S2$0.48
    S3$0.47

    Advanced Oscillators

    TSI15.63
    Ultimate Osc54.6
    KST225.91

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.84M$2.16M$2.06M$2.36M$2.32M$2.23M$2.01M$2.51M$1.85M$2.25M$2.26M$2.06M
    Cost of Revenue$930,871$598,009$556,313$719,247$705,860$584,985$502,453$677,585$442,560$572,742$750,940$555,850
    Gross Profit$1.91M$1.56M$1.50M$1.64M$1.62M$1.65M$1.51M$1.84M$1.41M$1.68M$1.51M$1.50M
    Operating Expenses$2.97M$2.39M$2.58M$2.78M$3.10M$3.65M$3.55M$3.31M$3.19M$3.14M$3.49M$3.01M
    R&D$6,609$0$12,334$16,226$51,789$369,120$217,532$232,056$314,968$94,211$176,906$170,478
    SG&A$2.95M$2.37M$2.55M$2.74M$3.03M$3.26M$3.33M$3.06M$2.87M$3.04M$3.30M$2.82M
    Operating Income$-1,061,563$-828,083$-1,079,662$-1,134,471$-1,484,631$-1,997,853$-2,042,287$-1,469,179$-1,780,423$-1,465,068$-1,979,543$-1,506,705
    Interest Income$2,231$-11,770$0$-19,488$1,521$3,267$0$8,008$0$0$0$0
    Interest Expense$0$11,770$10,899$19,488$0$0$0$0$-20,966$-24,539$-22,860$-30,600
    Income Before Tax$-1,059,332$-839,853$-1,090,561$-1,153,959$-1,483,110$-1,994,586$-2,035,535$-1,461,171$223,638$-1,440,529$-1,956,683$-1,476,105
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,059,332$-839,853$-1,090,561$-1,153,959$-1,483,110$-1,994,586$-2,035,535$-1,461,171$223,638$-1,440,529$-1,956,683$-1,476,105
    EBITDA$-1,012,664$-780,050$-1,029,375$-1,095,393$-1,433,654$-1,952,538$-2,008,328$-1,435,967$234,196$-1,428,920$-1,947,639$-1,467,366
    EBIT$-1,061,563$-828,083$-1,079,662$-1,134,471$-1,484,631$-1,997,853$-2,042,287$-1,469,179$202,672$-1,465,068$-1,979,543$-1,506,705
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MLSS

    News

    Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors

    Milestone Scientific Inc. announced that three of its directors converted $465,000 of outstanding company loans into common stock, making the company debt-free. This debt-to-equity conversion, executed at a 6.4% premium to the market price, resulted in the issuance of 976,870 shares. CEO Eric Hines stated this action strengthens the company's financial position and demonstrates the leadership's confidence in Milestone's future growth strategy.

    The Manila Times•8/26/26•
    Bullish

    Milestone Scientific Q2 revenue up 22%; affirms FY26 guidance

    Milestone Scientific reported a 22.3% year-over-year revenue increase to $2.841 million in Q2 2026, driven by a 231% surge in medical division sales. The company narrowed its net loss to $(0.01) per share and reaffirmed its full-year 2026 revenue guidance of $9.8 million to $10.2 million. Strategic developments include a federal distribution agreement with Red One Medical, clinical validation of CompuFlo, and AI integration for lead qualification.

    scanx.trade•8/20/26•
    Bullish

    Milestone Scientific | 8-K: Current report

    This article is a current report (Form 8-K) filed by Milestone Scientific. The content indicates a document was filed, but no further details are provided in this excerpt.

    Moomoo•8/20/26•
    Neutral

    Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1.5

    Maxim Group has reiterated its Buy rating for Milestone Scientific (MLSS.US) and maintained its price target of $1.5. This indicates a continued positive outlook on the company's stock performance from Maxim Group.

    Moomoo•8/19/26•
    Bullish

    Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Raises Target Price to $1.5

    Maxim Group has reiterated its Buy rating for Milestone Scientific (MLSS.US) and increased the target price to $1.5. This decision suggests a positive outlook on the company's future performance and stock value.

    Moomoo•8/19/26•
    Bullish

    Frequently Asked Questions About MLSS

    Does MLSS pay dividends?
    Milestone Scientific (MLSS) does not currently pay a regular dividend.
    What is MLSS's market cap?
    Milestone Scientific (MLSS) has a market capitalization of $42.31M with a current stock price of $0.48.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In